Neurostimulation Devices Market Size, Share, Trends, Growth Outlook

Neurostimulation Devices Market is estimated to increase at a growth rate of 11.5% CAGR over the forecast period from 2024 to 2030.

The global Neurostimulation Devices Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Electric Stimulator), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Others).

An introduction to Neurostimulation Devices Market in 2024

Revolutionizing the management of chronic pain and neurological disorders, the Neurostimulation Devices market offers implantable and external neuromodulation devices delivering electrical stimulation to targeted nerves or brain regions to modulate pain signals or restore neuronal function. Neurostimulation therapies include spinal cord stimulation (SCS), deep brain stimulation (DBS), and peripheral nerve stimulation (PNS), providing options for pain relief, movement disorders, epilepsy, and psychiatric conditions. The market's growth is driven by the increasing prevalence of chronic pain and neurological disorders, advancements in device technology, and expanding indications for neurostimulation therapies offering alternatives to traditional pharmacotherapy and surgery.

Neurostimulation Devices Market Trend: Technological Advancements and Innovations in Neurostimulation Devices

A significant trend in the neurostimulation devices market is the continuous technological advancements and innovations. Neurostimulation devices, including spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators, are increasingly becoming a preferred treatment option for various neurological disorders, such as chronic pain, movement disorders, and epilepsy. Recent advancements in device design, electrode technology, and programming algorithms have led to more precise and customizable stimulation parameters, resulting in improved therapeutic outcomes and patient satisfaction. Additionally, the integration of advanced features such as closed-loop systems and wireless connectivity further enhances the functionality and usability of neurostimulation devices, driving market growth and adoption.

Neurostimulation Devices Market Driver: Growing Prevalence of Chronic Neurological Disorders and Pain Conditions

The primary driver propelling the neurostimulation devices market is the growing prevalence of chronic neurological disorders and pain conditions. Chronic pain affects millions of individuals worldwide, significantly impacting their quality of life and productivity. Similarly, neurological disorders such as Parkinson's disease, epilepsy, and dystonia impose a substantial burden on patients, caregivers, and healthcare systems. Neurostimulation devices offer a non-pharmacological and minimally invasive treatment option for managing these chronic conditions, providing symptomatic relief and improving functional outcomes. As the global population ages and the burden of chronic neurological disorders and pain conditions continues to rise, there is a corresponding increase in demand for neurostimulation devices, driving market growth and adoption.

Neurostimulation Devices Market Opportunity: Expansion into Emerging Indications and Applications

An exciting opportunity in the neurostimulation devices market lies in the expansion into emerging indications and applications. While neurostimulation devices have traditionally been used for the management of chronic pain and movement disorders, there is growing interest in exploring their potential in addressing a broader range of neurological and psychiatric conditions. Opportunities for expansion include neuromodulation therapies for psychiatric disorders such as depression, anxiety, and obsessive-compulsive disorder, as well as innovative applications in areas such as migraine management, addiction treatment, and cognitive enhancement. By investing in research and development initiatives focused on exploring new indications and applications for neurostimulation devices, manufacturers can capitalize on this opportunity to diversify their product offerings, address unmet medical needs, and unlock new revenue streams in the evolving neurostimulation market.

Neurostimulation Devices Market Market Segmentation

By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Neurostimulation Devices Market Companies

Abbott
B. Braun SE
Boston Scientific Corp
Canon Inc
Carl Zeiss AG
Danaher Corp
GE Healthcare
Koninklijke Philips N.V.
Medtronic
Siemens Healthcare Private Ltd
Stryker
Terumo Corp

Reasons to Buy the Neurostimulation Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Neurostimulation Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Neurostimulation Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Neurostimulation Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Neurostimulation Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Neurostimulation Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Neurostimulation Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Neurostimulation Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Neurostimulation Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Neurostimulation Devices Industry
4.2 Key Market Trends in Neurostimulation Devices Industry
4.3 Potential Opportunities in Neurostimulation Devices Industry
4.4 Key Challenges in Neurostimulation Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Neurostimulation Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Neurostimulation Devices Market Outlook by Segments
7.1 Neurostimulation Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

8 North America Neurostimulation Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Neurostimulation Devices Markets in 2024
8.2 North America Neurostimulation Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Neurostimulation Devices Market size Outlook by Segments, 2021-2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

9 Europe Neurostimulation Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Neurostimulation Devices Markets in 2024
9.2 Europe Neurostimulation Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Neurostimulation Devices Market Size Outlook by Segments, 2021-2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

10 Asia Pacific Neurostimulation Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Neurostimulation Devices Markets in 2024
10.2 Asia Pacific Neurostimulation Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Neurostimulation Devices Market size Outlook by Segments, 2021-2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

11 South America Neurostimulation Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Neurostimulation Devices Markets in 2024
11.2 South America Neurostimulation Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Neurostimulation Devices Market size Outlook by Segments, 2021-2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

12 Middle East and Africa Neurostimulation Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Neurostimulation Devices Markets in 2024
12.2 Middle East and Africa Neurostimulation Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Neurostimulation Devices Market size Outlook by Segments, 2021-2030
By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott
B. Braun SE
Boston Scientific Corp
Canon Inc
Carl Zeiss AG
Danaher Corp
GE Healthcare
Koninklijke Philips N.V.
Medtronic
Siemens Healthcare Private Ltd
Stryker
Terumo Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Electric Stimulator
By Application
Pain Management
Epilepsy
Essential Tremor
Urinary and Fecal Incontinence
Depression
Dystonia
Gastroparesis
Parkinson’s Disease
Others